BioNTech
BNTX
$87.33
Share price
0.72%
Change (1 day)
-23.56%
Change (1 year)
BioNTech (BNTX) - Cash on Hand
Cash on Hand as of December 2023 : $18.29 B
According to BioNTech's latest financial reports the company has $18.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioNTech - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $15.06 B | 541.2% |
| 2021-12-31 | $2.34 B | 41.75% |
| 2020-12-31 | $1.65 B | 184.05% |
| 2019-12-31 | $0.58 B | 23.84% |
| 2018-12-31 | $0.47 B | 127.7% |
| 2017-12-31 | $0.20 B | -35.6% |
| 2016-12-31 | $0.32 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -98.86% | 🇺🇸 USA |